Page 169 - Read Online

Mooney et al. J Cancer Metastasis Treat 2019;5:19 I http://dx.doi.org/10.20517/2394-4722.2018.93 Page 17 of 17

plasma membrane of polarized epithelial cells. Proc Natl Acad Sci U S A 2004;101:5571-6.
35. Zhou S, Abdouh M, Arena V, Arena M, Arena GO. Reprogramming malignant cancer cells toward a benign phenotype following exposure
to human embryonic stem cell microenvironment. PLoS One 2017;12:e0169899.
36. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, et al. Human embryonic stem cell microenvironment suppresses the
tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 2008;105:4329-34.
37. He N, Feng G, Li Y, Xu Y, Xie X, et al. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast
cancer. Stem Cell Res Ther 2016;7:95.
38. Dong W, Qiu C, Shen H, Liu Q, Du J. Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and
immune responses. Int J Med Sci 2013;10:1314-20.
39. Giuffrida D, Rogers IM, Nagy A, Calogero AE, Brown TJ, et al. Human embryonic stem cells secrete soluble factors that inhibit cancer cell
growth. Cell Prolif 2009;42:788-98.
40. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation
of human embryonic stem cells. Proc Natl Acad Sci 2007;104:11298-303.
41. Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free
maintenance. Biomaterials 2008;29:3946-52.
42. Wang W, Liu X, Xie Y, Zhang Ha, Yu W, et al. Microencapsulation using natural polysaccharides for drug delivery and cell implantation. J
Mater Chem 2006;16:3252-67.
43. Li Z, Leung M, Hopper R, Ellenbogen R, Zhang M. Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer
scaffolds. Biomaterials 2010;31:404-12.
44. Watson AL, Rahrmann EP, Moriarity BS, Choi K, Conboy CB, et al. Canonical Wnt/β-catenin signaling drives human schwann cell
transformation, progression, and tumor maintenance. Cancer Discovery 2013;3:674-89.
45. Hazan RB, Norton L. The epidermal growth factor receptor modulates the Interaction of E-cadherin with the actin cytoskeleton. J Biol
Chem 1998;273:9078-84.
46. Mangelberger D, Kern D, Loipetzberger A, Eberl M, Aberger F. Cooperative Hedgehog-EGFR signaling. Front biosci (Landmark Ed)
2012;17:90-9.
47. Lim SO, Li CW, Xia W, Lee HH, Chang SS, et al. EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to
promote tumor growth and immune escape. Cancer Res 2016;76:1284-96.
48. Takebe N, Warren RQ, Ivy SP. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and
epithelial-to-mesenchymal transition. Breast Cancer Res 2011;13:211.
49. Maltseva DV, Khaustova NA, Fedotov NN, Matveeva EO, Lebedev AE, et al. High-throughput identification of reference genes for research
and clinical RT-qPCR analysis of breast cancer samples. J Clin Bioinforma 2013;3:13.
50. Jacquin MA, Chiche J, Zunino B, Bénéteau M, Meynet O, et al. GAPDH binds to active Akt, leading to Bcl-xL increase and escape from
caspase-independent cell death. Cell Death Differ 2013;20:1043.
51. Luetteke NC, Lee DC. Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor.
Semin Canc Biol 1990;1:265-75.
52. Geng F, Zhu W, Anderson RA, Leber B, Andrews DW. Multiple post-translational modifications regulate E-cadherin transport during
apoptosis. J Cell Sci 2012;125:2615-25.
53. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, et al. Phosphorylation of B-catenin by AKT promotes B-catenin transcriptional activity.
J Biol Chem 2007;282:11221-29.